» Articles » PMID: 15696105

Eosinophilic Esophagitis: Escalating Epidemiology?

Overview
Date 2005 Feb 8
PMID 15696105
Citations 133
Authors
Affiliations
Soon will be listed here.
Citing Articles

The clinical impact of conventional therapies for adults and adolescents suffering from eosinophilic esophagitis, a type 2 inflammatory chronic disease, and their economic consequences in Italy: Systematic literature review and meta-analysis.

Canonica G, Mazziotti G, Repici A, Povero M, Castello L, Pradelli L J Allergy Clin Immunol Glob. 2025; 4(1):100383.

PMID: 39877128 PMC: 11773236. DOI: 10.1016/j.jacig.2024.100383.


Cohort Profile Update: The Swiss Eosinophilic Esophagitis Cohort Study (SEECS).

Wakim El-Khoury J, Safroneeva E, Saner C, Rossel J, Trelle S, Zwahlen M Inflamm Intest Dis. 2024; 9(1):165-173.

PMID: 39144837 PMC: 11324224. DOI: 10.1159/000539713.


Incidence and prevalence of eosinophilic oesophagitis across Europe: A systematic review and meta-analysis.

Roberts S, Morrison-Rees S, Thapar N, Williams J United European Gastroenterol J. 2023; 12(1):89-102.

PMID: 37921701 PMC: 10859717. DOI: 10.1002/ueg2.12465.


Current and Novel Therapies for Eosinophilic Gastrointestinal Diseases.

Marasco G, Visaggi P, Vassallo M, Fiocca M, Cremon C, Barbaro M Int J Mol Sci. 2023; 24(20).

PMID: 37894846 PMC: 10607071. DOI: 10.3390/ijms242015165.


Hospitalization Trends and Outcomes of Eosinophilic Esophagitis in the United States: A Decade-Long Nationwide Analysis.

Kwei-Nsoro R, Ojemolon P, Attar B, Shaka H, Zarza-Gulino P, Asare M Cureus. 2023; 15(8):e44315.

PMID: 37779798 PMC: 10536399. DOI: 10.7759/cureus.44315.